{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:42:58Z","timestamp":1791614578951,"version":"4.3.4"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,9,9]],"date-time":"2017-09-09T00:00:00Z","timestamp":1504915200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,9,9]],"date-time":"2017-09-09T00:00:00Z","timestamp":1504915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"US Public Health Service"},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"crossref"}]},{"name":"US Public Health Service"},{"name":"The Sackler School of Medicine, Tel-Aviv University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12929-017-0377-1","type":"journal-article","created":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T09:51:51Z","timestamp":1505123511000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Repositioning drugs for traumatic brain injury - N-acetyl cysteine and Phenserine"],"prefix":"10.1186","volume":"24","author":[{"given":"Barry J.","family":"Hoffer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaim G.","family":"Pick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Hoffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Hsiao","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel H.","family":"Greig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,9]]},"reference":[{"key":"377_CR1","first-page":"341","volume":"22","author":"AA Hyder","year":"2007","unstructured":"Hyder AA, Wunderlich CA, Puvanachandra P, Gururaj G, Ko-busingye OC. The impact of traumatic brain injuries: a global perspective. Neuro Rehabilitation. 2007;22:341\u201353.","journal-title":"Neuro Rehabilitation"},{"key":"377_CR2","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1001\/jama.2012.14008","volume":"308","author":"RL Ruff","year":"2012","unstructured":"Ruff RL, Riechers RG. Effective treatment of traumatic brain injury: learning from experience. JAMA. 2012;308:2032\u20133.","journal-title":"JAMA"},{"key":"377_CR3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/00001199-200609000-00001","volume":"21","author":"JA Langlois","year":"2006","unstructured":"Langlois JA, Rutland-Brown W, Wald MM. The epidemiology and impact of traumatic brain injury: a brief overview. J Head Trauma Rehabil. 2006;21:375\u20138.","journal-title":"J Head Trauma Rehabil"},{"key":"377_CR4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijdevneu.2011.05.009","volume":"30","author":"ML Prins","year":"2012","unstructured":"Prins ML, Giza CC. Repeat traumatic brain injury in the developing brain. Int J Dev Neurosci. 2012;30:185\u201390.","journal-title":"Int J Dev Neurosci"},{"key":"377_CR5","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00701-005-0651-y","volume":"148","author":"F Tagliaferri","year":"2006","unstructured":"Tagliaferri F, Compagnone C, Korsic M, Servadei F, Kraus J. Systematic review of brain injury epidemiology in Europe. Acta Neurochir. 2006;148:255\u201368.","journal-title":"Acta Neurochir"},{"key":"377_CR6","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3171\/2012.12.JNS12693","volume":"118","author":"HY Shi","year":"2013","unstructured":"Shi HY, Hwang SL, Lee KT, Lin CL. Temporal trends and volume-outcome associations after traumatic brain injury: a 12- year study in Taiwan. Clinical article J Neurosurg. 2013;118:732\u20138.","journal-title":"Clinical article J Neurosurg"},{"issue":"12","key":"377_CR7","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1001\/jamaneurol.2014.2668","volume":"71","author":"RC Gardner","year":"2014","unstructured":"Gardner RC, Burke JF, Nettiksimmons J, Kaup A, Barnes DE, Yaffe K. Dementia risk after traumatic brain injury vs nonbrain trauma: the role of age and severity. JAMA Neurol. 2014;71(12):1490\u20137. doi: 10.1001\/jamaneurol.2014.2668 .","journal-title":"JAMA Neurol."},{"issue":"4","key":"377_CR8","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1212\/WNL.0000000000000616","volume":"83","author":"DE Barnes","year":"2014","unstructured":"Barnes DE, Kaup A, Kirby KA, Byers AL, Diaz-Arrastia R, Yaffe K. Traumatic brain injury and risk of dementia in older veterans. Neurology. 2014;83(4):312\u20139.","journal-title":"Neurology"},{"key":"377_CR9","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/ana.24254","volume":"76","author":"NH Greig","year":"2014","unstructured":"Greig NH, Sambamurti K, Lahiri DK, Becker RE. Amyloid-\u03b2 precursor protein synthesis inhibitors for Alzheimer's disease treatment. Ann Neurol. 2014;76:629\u201330.","journal-title":"Ann Neurol"},{"key":"377_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2013.02.006","volume":"54","author":"D Tweedie","year":"2013","unstructured":"Tweedie D, Rachmany L, Rubovitch V, Zhang Y, Becker KG, Perez E, et al. Changes in mouse cognition and hippocampal gene expression observed in a mild physical- and blast-traumatic brain injury. Neurobiol Dis. 2013;54:1\u201311.","journal-title":"Neurobiol Dis"},{"key":"377_CR11","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.expneurol.2012.10.001","volume":"239","author":"D Tweedie","year":"2013","unstructured":"Tweedie D, Rachmany L, Rubovitch V, Lehrmann E, Zhang Y, Becker KG, et al. Exendin-4, a glucagon-like peptide-1 receptor agonist prevents mTBI-induced changes in hippocampus gene expression and memory deficits in mice. Exp Neurol. 2013;239:170\u201382.","journal-title":"Exp Neurol"},{"issue":"134","key":"377_CR12","doi-asserted-by":"publisher","first-page":"134ra60","DOI":"10.1126\/scitranslmed.3003716","volume":"4","author":"LE Goldstein","year":"2012","unstructured":"Goldstein LE, Fisher AM, Tagge CA, et al. Chronic traumatic encephalopathy in blast-exposed military veterans and a blast neurotrauma mouse model. Sci Transl Med. 2012;4(134):134ra60.","journal-title":"Sci Transl Med"},{"key":"377_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0079-6123(06)61002-9","volume":"161","author":"MC LaPlaca","year":"2007","unstructured":"LaPlaca MC, Simon CM, Prado GR, Cullen DK. CNS injury biomechanics and experimental models. Prog Brain Res. 2007;161:13\u201326.","journal-title":"Prog Brain Res"},{"key":"377_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.csm.2010.09.001","volume":"30","author":"G Barkhoudarian","year":"2011","unstructured":"Barkhoudarian G, Hovda DA, Giza C. The molecular pathophysiology of concussive brain injury. Clin Sports Med. 2011;30:33\u201348.","journal-title":"Clin Sports Med"},{"key":"377_CR15","doi-asserted-by":"crossref","unstructured":"Greve MW, Zink BJ. Pathophysiology of traumatic brain injury. Mt Sinai J Med. 2009;76(2):97\u2013104.","DOI":"10.1002\/msj.20104"},{"key":"377_CR16","doi-asserted-by":"publisher","unstructured":"Bachstetter AD, Norris CM, Sompol P, Wilcock DM, Goulding D, Neltner JH, et al. Early stage drug treatment that normalizes proinflammatory cytokine production attenuates synaptic dysfunction in a mouse model that exhibits age-dependent progression of Alzheimer's disease-related pathology. J Neurosci. 2012;32:10201\u201310. doi: 10.1523\/JNEUROSCI.1496-12.2012 .","DOI":"10.1523\/JNEUROSCI.1496-12.2012"},{"key":"377_CR17","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.brainresrev.2004.12.028","volume":"48","author":"OI Schmidt","year":"2005","unstructured":"Schmidt OI, Heyde CE, Ertel W, Stahel PF. Closed head injury - an inflammatory disease? Brain Res Rev. 2005;48:388\u201399.","journal-title":"Brain Res Rev"},{"key":"377_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/bja\/aem128","volume":"99","author":"IK Moppett","year":"2007","unstructured":"Moppett IK. Traumatic brain injury: assessment, resuscitation and early management. Br J Anaesth. 2007;99:18\u201331.","journal-title":"Br J Anaesth"},{"key":"377_CR19","doi-asserted-by":"publisher","unstructured":"Chen G, Shi J, Hu Z, Hang C. Inhibitory effect on cerebral inflammatory response following traumatic brain injury in rats: a potential neuroprotective mechanism of N-acetylcysteine. Mediat Inflamm. 2008;2008:716458. doi: 10.1155\/2008\/716458 .","DOI":"10.1155\/2008\/716458"},{"issue":"5","key":"377_CR20","doi-asserted-by":"publisher","first-page":"774","DOI":"10.3171\/jns.1991.75.5.0774","volume":"75","author":"EF Ellis","year":"1991","unstructured":"Ellis EF, Dodson LY, Police RJ. Restoration of cerebrovascular responsiveness to hyperventilation by the oxygen radical scavenger n-acetylcysteine. J Neurosurg. 1991;75(5):774\u20139.","journal-title":"J Neurosurg"},{"key":"377_CR21","first-page":"A109","volume":"29","author":"P Bergold","year":"2012","unstructured":"Bergold P, Haber M, Dash P, Grill R, Grin\u2019kina N, Abdel-Baki S. Minocycline and N-Acetlycysteine modulates neuroinflammation and produces remyelination following controlled cortical impact. J Neurotrauma. 2012;29:A109\u201310.","journal-title":"J Neurotrauma"},{"key":"377_CR22","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s11064-006-9040-z","volume":"31","author":"T Hicdonmez","year":"2006","unstructured":"Hicdonmez T, Kanter M, Tiryaki M, Parsak T, Cobanoglu S. Neuroprotective effects of N-acetylcysteine on experimental closed head trauma in rats. Neurochem Res. 2006;31:473\u201348.","journal-title":"Neurochem Res"},{"key":"377_CR23","first-page":"519","volume":"76","author":"M Khan","year":"2004","unstructured":"Khan M, Sekhon B, Jatana M, Giri S, Gilg AG, Sekhon C, Singh I, Singh AK. Administration of Nacetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke. J Res. 2004;76:519\u201327.","journal-title":"J Res"},{"key":"377_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0006-8993(03)02244-3","volume":"971","author":"B Sekhon","year":"2003","unstructured":"Sekhon B, Sekhon C, Khan M, Patel SJ, Singh I, Singh AK. N-acetyl cysteine protects against injury in a rat model of focal cerebral ischemia. Brain Res. 2003;971:1\u20138.","journal-title":"Brain Res"},{"key":"377_CR25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1124\/pr.54.2.271","volume":"54","author":"Y Gilgun-Sherki","year":"2002","unstructured":"Gilgun-Sherki Y, Rosenbaum Z, Melamed E, Offen D. Antioxidant therapy in acute central nervous system injury: current state. Pharmacol Rev. 2002;54:271\u201384.","journal-title":"Pharmacol Rev"},{"key":"377_CR26","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.2174\/0929867033456567","volume":"10","author":"F Santangelo","year":"2003","unstructured":"Santangelo F. Intracellular thiol concentration modulating inflammatory response: influence on the regulation of cell functions through cysteine prodrug approach. Curr Med Chem. 2003;10:2599\u2013610.","journal-title":"Curr Med Chem"},{"key":"377_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0891-5849(97)00137-8","volume":"24","author":"K Pahan","year":"1998","unstructured":"Pahan K, Sheikh FG, Namboodiri AMS, Singh I. Nacetylcysteine inhibits induction of NO production by endotoxin or cytokine stimulated rat peritoneal macrophages, C6 glial cells and astrocytes. Free Radic Biol Med. 1998;24:39\u201348.","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"377_CR28","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1210\/jc.2002-021677","volume":"88","author":"M Lappas","year":"2003","unstructured":"Lappas M, Permezel M, Rice GE. N-acetyl-cysteine inhibits phospholipid metabolism, proinflammatory cytokine release, protease activity, and nuclear factor-kappaB deoxyribonucleic acid-binding activity in human fetal membranes in vitro. J Clin Endocrinol Metab. 2003;88(4):1723\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"377_CR29","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/sj.bjp.0703421","volume":"130","author":"S Cuzzocrea","year":"2000","unstructured":"Cuzzocrea S, Mazzon E, Costantino G, Serraino I, Dugo L, Calabro G, et al. Beneficial effects of nacetylcysteine on ischaemic brain injury. Br J Pharmacol. 2000;130:1219\u201326.","journal-title":"Br J Pharmacol"},{"key":"377_CR30","doi-asserted-by":"crossref","unstructured":"Tsai SY, Hayashi T, Harvey BK, Wang Y, Wu WW, Shen RF, et al. Sigma-1 receptors regulate hippocampal dendritic spine formation via a free radical-sensitive mechanism involving Rac1\u2022GTP pathway. PNAS. 2009;106(52):22468-73.","DOI":"10.1073\/pnas.0909089106"},{"issue":"4","key":"377_CR31","doi-asserted-by":"publisher","first-page":"e90617","DOI":"10.1371\/journal.pone.0090617","volume":"9","author":"K Eakin","year":"2014","unstructured":"Eakin K, Baratz-Goldstein R, Pick CG, Zindel O, Balaban CD, Hoffer ME, et al. Efficacy of N-acetyl cysteine in traumatic brain injury. PLoS One. 2014;9(4):e90617. doi: 10.1371\/journal.pone.009061 .","journal-title":"PLoS One"},{"key":"377_CR32","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1046\/j.1471-4159.2003.01580.x","volume":"84","author":"SA Farr","year":"2003","unstructured":"Farr SA, Poon HF, Dogrukol-Ak D, Drake J, Banks WA, Eyerman E, et al. The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J Neurochem. 2003;84:1173\u201383.","journal-title":"J Neurochem"},{"key":"377_CR33","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1002\/hipo.20421","volume":"18","author":"F Lant\u00e9","year":"2008","unstructured":"Lant\u00e9 F, Meunier J, Guiramand J, De Jesus Ferreira MC, Cambonie G, Aimar R, et al. Late N-acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation. Hippocampus. 2008;18:602\u20139.","journal-title":"Hippocampus"},{"key":"377_CR34","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.biopsych.2011.07.035","volume":"71","author":"J Miguel","year":"2012","unstructured":"Miguel J, Kulak A, Gholam-Razaee MM, Cuenod M, Gruetter R, Do KQ. N-Acetylcysteine normalizes Neurochemical changes in the glutathione-deficient schizophrenia mouse model during development. Biol Psychiatry. 2012;71:1006\u201314.","journal-title":"Biol Psychiatry"},{"key":"377_CR35","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nature12808","volume":"505","author":"TL Roth","year":"2014","unstructured":"Roth TL, Nayak D, Atanasijevic T, Koretsky AP, Latour LL, McGavern DB. Transcranial amelioration of inflammation and cell death after brain injury. Nature. 2014;505:223\u20138. doi: 10.1038\/nature12808 .","journal-title":"Nature"},{"key":"377_CR36","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nn.2250","volume":"12","author":"K Moussawi","year":"2009","unstructured":"Moussawi K, Pacchioni A, Moran M, Olive MF, Gass JT, Lavin A, et al. NAcetylcysteine reverses cocaine-induced metaplasticity. Nat Neurosci. 2009;12:182\u20139.","journal-title":"Nat Neurosci"},{"key":"377_CR37","doi-asserted-by":"publisher","first-page":"e54163","DOI":"10.1371\/journal.pone.0054163","volume":"8","author":"ME Hoffer","year":"2013","unstructured":"Hoffer ME, Balaban C, Slade MD, Tsao JW, Hoffer B. Amelioration of acute sequelae of blast induced mild traumatic brain injury by N-acetyl cysteine: a double-blind, placebo controlled study. PLoS One. 2013;8:e54163.","journal-title":"PLoS One"},{"key":"377_CR38","doi-asserted-by":"publisher","unstructured":"Diaz-Arrastia R, Kochanek PM, Bergold P, Kenney K, Marx C, Grimes J, et al. Pharmacotherapy of traumatic brain injury: state of the science and the road forward report of the Department of Defense Neurotrauma Pharmacology Workgroup. J Neurotrauma. 2014;31(2):135\u201358. doi: 10.1089\/neu.2013.3019 .","DOI":"10.1089\/neu.2013.3019"},{"key":"377_CR39","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1089\/089771502762300238","volume":"19","author":"SL Verbois","year":"2002","unstructured":"Verbois SL, Scheff SW, Pauly JR. Time-dependent changes in rat brain cholinergic receptor expression after experimental brain injury. J Neurotrauma. 2002;19:1569\u201385.","journal-title":"J Neurotrauma"},{"key":"377_CR40","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1089\/neu.1998.15.295","volume":"15","author":"I Murdoch","year":"1998","unstructured":"Murdoch I, Perry EK, Court JA, Graham DI, Dewar D. Cortical cholinergic dysfunction after human head injury. J Neurotrauma. 1998;15:295\u2013305.","journal-title":"J Neurotrauma"},{"key":"377_CR41","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1089\/neu.1996.13.181","volume":"13","author":"D Dewar","year":"1996","unstructured":"Dewar D, Graham DI. Depletion of choline acetyltransferase activity but preservation of M1 and M2 muscarinic receptor binding sites in temporal cortex following head injury: a preliminary human post-mortem study. J Neurotrauma. 1996;13:181\u20137.","journal-title":"J Neurotrauma"},{"key":"377_CR42","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3171\/jns.1995.83.3.0496","volume":"83","author":"RH Schmidt","year":"1995","unstructured":"Schmidt RH, Grady MS. Loss of forebrain cholinergic neurons following fluid-percussion injury: implications for cognitive impairment in closed head injury. J Neurosurg. 1995;83:496\u2013502.","journal-title":"J Neurosurg"},{"key":"377_CR43","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/02699050802132495","volume":"22","author":"NA Poole","year":"2008","unstructured":"Poole NA, Agrawal N. Cholinomimetic agents and neurocognitive impairment following head injury: a systematic review. Brain Inj. 2008;22:519\u201334.","journal-title":"Brain Inj"},{"key":"377_CR44","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1089\/neu.2011.1978","volume":"28","author":"DP Holschneider","year":"2011","unstructured":"Holschneider DP, Guo Y, Roch M, Norman KM, Scremin OU. Acetylcholinesterase inhibition and locomotor function after motor-sensory cortex impact injury. J Neurotrauma. 2011;28:1909\u201319.","journal-title":"J Neurotrauma"},{"key":"377_CR45","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1089\/neu.2012.2782","volume":"30","author":"KE Shaw","year":"2013","unstructured":"Shaw KE, Bondi CO, Light SH, Massimino LA, McAloon RL, Monaco CM, Kline AE. Donepezil is ineffective in promoting motor and cognitive benefits after controlled cortical impact injury in male rats. J Neurotrauma. 2013;30:557\u201364.","journal-title":"J Neurotrauma"},{"key":"377_CR46","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/S1474-4422(08)70164-9","volume":"7","author":"AIR Maas","year":"2008","unstructured":"Maas AIR, Stocchetti N, Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol. 2008;7:728\u201341.","journal-title":"Lancet Neurol"},{"key":"377_CR47","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1089\/ars.2012.4981","volume":"19","author":"C Cornelius","year":"2013","unstructured":"Cornelius C, Crupi R, Calabrese V, Graziano A, Milone P, Pennisi G, et al. Traumatic brain injury: oxidative stress and neuroprotection. Antioxid Redox Signal. 2013;19:836\u201353. doi: 10.1089\/ars.2012.4981 .","journal-title":"Antioxid Redox Signal"},{"key":"377_CR48","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1152\/jn.1946.9.5.349","volume":"9","author":"MB Bornstein","year":"1946","unstructured":"Bornstein MB. Presence and action of acetylcholine in experimental brain trauma. J Neurophysiol. 1946;9:349\u201366.","journal-title":"J Neurophysiol"},{"key":"377_CR49","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3171\/jns.1957.14.1.0022","volume":"14","author":"E Sachs Jr","year":"1957","unstructured":"Sachs E Jr. Acetylcholine and serotonin in the spinal fluid. J Neurosurg. 1957;14:22\u20137.","journal-title":"J Neurosurg"},{"key":"377_CR50","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3171\/jns.1971.35.5.0523","volume":"35","author":"B Metz","year":"1971","unstructured":"Metz B. Acetylcholine and experimental brain injury. J Neurosurg. 1971;35:523\u20138.","journal-title":"J Neurosurg"},{"key":"377_CR51","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/BF03160117","volume":"18","author":"BG Lyeth","year":"1993","unstructured":"Lyeth BG, Jiang JY, Robinson SE, Guo H, Jenkins LW. Hypothermia blunts acetylcholine increase in CSF of traumatically brain injured rats. Mol Chem Neuropathol. 1993a;18:247\u201356.","journal-title":"Mol Chem Neuropathol"},{"key":"377_CR52","first-page":"105","volume":"27","author":"DB Tower","year":"1949","unstructured":"Tower DB, McEachern D. Acetylcholine and neuronal activity. I. Cholinesterase patterns and acetylcholine in the cerebrospinal fluid of patients with craniocerebral trauma. Canad J Biochem. 1949;27:105\u201319.","journal-title":"Canad J Biochem"},{"key":"377_CR53","doi-asserted-by":"crossref","unstructured":"Ward AA. Jr Atropine in the treatment of closed head injury. J Neurosurg;1950;7: 398\u2013402.","DOI":"10.3171\/jns.1950.7.5.0398"},{"key":"377_CR54","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3171\/jns.1954.11.1.0077","volume":"11","author":"D Ruge","year":"1954","unstructured":"Ruge D. The use of cholinergic blocking agents in the treatment of cranio-cerebral injuries. J Neurosurg. 1954;11:77\u201383.","journal-title":"J Neurosurg"},{"key":"377_CR55","first-page":"560","volume":"75","author":"H Lechner","year":"1963","unstructured":"Lechner H. Anticholinergic therapy of craniocerebral trauma. Wien Klin Wochenschr. 1963;75:560.","journal-title":"Wien Klin Wochenschr"},{"key":"377_CR56","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0006-8993(93)90614-S","volume":"617","author":"BG Lyeth","year":"1993","unstructured":"Lyeth BG, Liu S, Hamm RJ. Combined scopolamine and morphine treatment of traumatic brain injury in the rat. Brain Res. 1993b;617:69\u201375.","journal-title":"Brain Res"},{"key":"377_CR57","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1089\/neu.2008.0671","volume":"25","author":"CD Cox","year":"2008","unstructured":"Cox CD, West EJ, Liu MC, Wang KK, Hayes RL, Lyeth BG. Dicyclomine, an M1 muscarinic antagonist, reduces biomarker levels, but not neuronal degeneration, in fluid percussion brain injury. J Neurotrauma. 2008;25:1355\u201365.","journal-title":"J Neurotrauma"},{"issue":"6","key":"377_CR58","doi-asserted-by":"publisher","first-page":"e0156493","DOI":"10.1371\/journal.pone.0156493","volume":"11","author":"D Tweedie","year":"2016","unstructured":"Tweedie D, Fukui K, Li Y, Yu QS, Barak S, Tamargo IA, et al. Cognitive impairments induced by concussive mild traumatic brain injury in mouse are ameliorated by treatment with Phenserine via multiple non-cholinergic and cholinergic mechanisms. PLoS One. 2016;11(6):e0156493. doi: 10.1371\/journal.pone.0156493 . eCollection 2016","journal-title":"PLoS One"},{"key":"377_CR59","doi-asserted-by":"publisher","first-page":"e79837","DOI":"10.1371\/journal.pone.0079837","volume":"8","author":"L Rachmany","year":"2013","unstructured":"Rachmany L, Tweedie D, Rubovitch V, Yu QS, Li Y, Wang JY, et al. Cognitive impairments accompanying rodent mild traumatic brain injury involve p53-dependent neuronal cell death and are ameliorated by the tetrahydrobenzothiazole PFT-\u03b1. PLoS One. 2013;8:e79837.","journal-title":"PLoS One"},{"key":"377_CR60","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S0306-4522(03)00048-4","volume":"118","author":"O Zohar","year":"2003","unstructured":"Zohar O, Schreiber S, Getslev V, Schwartz JP, Mullins PG, Pick CG. Closed-head minimal traumatic brain injury produces long-term cognitive deficits in mice. Neuroscience. 2003;118:949\u201355.","journal-title":"Neuroscience"},{"key":"377_CR61","doi-asserted-by":"crossref","first-page":"36","DOI":"10.55782\/ane-2011-1821","volume":"71","author":"O Zohar","year":"2011","unstructured":"Zohar O, Rubovitch V, Milman A, Schreiber S, Pick CG. Behavioral consequences of minimal traumatic brain injury in mice. Acta Neurobiol Exp. 2011;71:36\u201345.","journal-title":"Acta Neurobiol Exp"},{"key":"377_CR62","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1089\/neu.2005.22.1003","volume":"22","author":"A Milman","year":"2005","unstructured":"Milman A, Rosenberg A, Weizman R, Pick CG. Mild traumatic brain injury induces persistent cognitive deficits and behavioral disturbances in mice. J Neurotrauma. 2005;22:1003\u201310.","journal-title":"J Neurotrauma"},{"key":"377_CR63","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/j.1471-4159.2011.07377.x","volume":"118","author":"R Baratz","year":"2010","unstructured":"Baratz R, Tweedie D, Rubovitch V, Luo W, Yoon JS, Hoffer BJ, et al. Tumor necrosis factor-\u03b1 synthesis inhibitor, 3,6\u2032-dithiothalidomide, reverses behavioral impairments induced by minimal traumatic brain injury in mice. J Neurochem. 2010;118:1032\u201342.","journal-title":"J Neurochem"},{"issue":"1 Suppl","key":"377_CR64","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1016\/j.jalz.2013.12.011","volume":"10","author":"NH Greig","year":"2014","unstructured":"Greig NH, Tweedie D, Rachmany L, Li Y, Rubovitch V, Schreiber S, Chiang YH, et al. Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury. Alzheimers Dement. 2014;10(1 Suppl):S62\u201375.","journal-title":"Alzheimers Dement"},{"issue":"Pt B","key":"377_CR65","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.mcn.2015.03.001","volume":"66","author":"RC Gardner","year":"2015","unstructured":"Gardner RC, Yaffe K. Epidemiology of mild traumatic brain injury and neurodegenerative disease. Mol Cell Neurosci. 2015;66(Pt B):75\u201380.","journal-title":"Mol Cell Neurosci"},{"key":"377_CR66","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1001\/jamaneurol.2016.1948","volume":"73","author":"PK Crane","year":"2016","unstructured":"Crane PK, Gibbons LE, Dams-O'Connor K, Trittschuh E, Leverenz JB, Keene CD, et al. Association of Traumatic Brain Injury with Late-Life Neurodegenerative Conditions and Neuropathologic Findings. JAMA Neurol. 2016;73:1062\u20139.","journal-title":"JAMA Neurol."},{"key":"377_CR67","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11920-016-0719-9","volume":"18","author":"JS Young","year":"2016","unstructured":"Young JS, Hobbs JG, Bailes JE. The impact of traumatic brain injury on the aging brain. Curr Psychiatry Rep. 2016;18:81.","journal-title":"Curr Psychiatry Rep"},{"key":"377_CR68","doi-asserted-by":"publisher","first-page":"608","DOI":"10.2174\/1567205010666131212113218","volume":"11","author":"M Reale","year":"2014","unstructured":"Reale M, Di Nicola M, Velluto L, D'Angelo C, Costantini E, Lahiri DK, et al. Selective acetyl- and butyrylcholinesterase inhibitors reduce amyloid-\u03b2 ex vivo activation of peripheral chemo-cytokines from Alzheimer's disease subjects: exploring the cholinergic anti-inflammatory pathway. Curr Alzheimer Res. 2014;11:608\u201322.","journal-title":"Curr Alzheimer Res"},{"key":"377_CR69","first-page":"97","volume":"11","author":"D Lozano","year":"2015","unstructured":"Lozano D, Gonzales-Portillo GS, Acosta S, de la Pena I, Tajiri N, Kaneko Y, et al. Neuroinflammatory responses to traumatic brain injury: etiology, clinical consequences, and therapeutic opportunities. Neuropsychiatr. Dis. Treat. 2015;11:97\u2013106.","journal-title":"Treat"},{"key":"377_CR70","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10787-012-0164-2","volume":"21","author":"JW Finnie","year":"2013","unstructured":"Finnie JW. Neuroinflammation: beneficial and detrimental effects after traumatic brain injury. Inflammopharmacology. 2013;21:309\u201320.","journal-title":"Inflammopharmacology"},{"key":"377_CR71","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/med.2610150103","volume":"15","author":"NH Greig","year":"1995","unstructured":"Greig NH, Pei XF, Soncrant TT, Ingram DK, Brossi A. Phenserine and ring C hetero-analogues: drug candidates for the treatment of Alzheimer's disease. Med Res Rev. 1995;15:3\u201331.","journal-title":"Med Res Rev"},{"key":"377_CR72","doi-asserted-by":"crossref","unstructured":"Greig NH, Ruckle J, Comer P, Brownell L, Holloway HW, Flanagan DR Jr, et al. Anticholinesterase and pharmacokinetic profile of phenserine in healthy elderly human subjects. Curr Alzheimer Res 2005;2:483-492.","DOI":"10.2174\/156720505774330564"},{"key":"377_CR73","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3233\/JAD-2010-101311","volume":"22","author":"B Winblad","year":"2010","unstructured":"Winblad B, Giacobini E, Fr\u00f6lich L, Friedhoff LT, Bruinsma G, Becker RE, et al. Phenserine efficacy in Alzheimer's disease. J Alzheimers Dis. 2010;22:1201\u20138.","journal-title":"J Alzheimers Dis"},{"key":"377_CR74","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1021\/jm9800494","volume":"41","author":"Q Yu","year":"1998","unstructured":"Yu Q, Greig NH, Holloway HW, Brossi A. Syntheses and anticholinesterase activities of (3aS)-N1, N8-bisnorphenserine, (3aS)-N1,N8-bisnorphysostigmine, their antipodal isomers, and other potential metabolites of phenserine. J Med Chem. 1998;41:2371\u20139.","journal-title":"J Med Chem"},{"key":"377_CR75","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2174\/1871523011312020003","volume":"12","author":"QS Yu","year":"2013","unstructured":"Yu QS, Reale M, Kamal MA, Holloway HW, Luo W, Sambamurti K, et al. Synthesis of the Alzheimer drug Posiphen into its primary metabolic products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their inhibition of amyloid precursor protein, \u03b1-Synuclein synthesis, interleukin-1\u03b2 release, and cholinergic action. Antinflamm Antiallergy Agents Med Chem. 2013;12:117\u201328.","journal-title":"Antinflamm Antiallergy Agents Med Chem"},{"key":"377_CR76","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2174\/187152711794653751","volume":"10","author":"KA Frankola","year":"2011","unstructured":"Frankola KA, Greig NH, Luo W, Tweedie D. Targeting TNF-\u03b1 to elucidate and ameliorate neuroinflammation in neurodegenerative diseases. CNS Neurol Disord Drug Targets. 2011;10:391\u2013403.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"377_CR77","first-page":"100","volume":"5","author":"YC Chen","year":"2014","unstructured":"Chen YC, Mao H, Yang KH, Abel T, Meaney DF. A controlled cortical impact technique of model mild traumatic brain injury mechanics in mice. Front Neruol. 2014;5:100.","journal-title":"Front Neruol"},{"issue":"1","key":"377_CR78","doi-asserted-by":"publisher","first-page":"e54887","DOI":"10.1371\/journal.pone.0054887","volume":"8","author":"AM Lilja","year":"2013","unstructured":"Lilja AM, Luo Y, Yu QS, R\u00f6jdner J, Li Y, Marini AM, et al. Neurotrophic and neuroprotective actions of (\u2212)- and (+)-phenserine, candidate drugs for Alzheimer\u2019s disease. PLoS One. 2013;8(1):e54887.","journal-title":"PLoS One"},{"key":"377_CR79","doi-asserted-by":"publisher","first-page":"7605","DOI":"10.1073\/pnas.131152998","volume":"98","author":"KT Shaw","year":"2001","unstructured":"Shaw KT, Utsuki T, Rogers J, Yu QS, Sambamurti K, Brossi A. Phenserine regulates translation of beta -amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug development. PNAS. 2001;98:7605\u201310.","journal-title":"PNAS"},{"key":"377_CR80","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1124\/jpet.106.112102","volume":"320","author":"DK Lahiri","year":"2007","unstructured":"Lahiri DK, Chen D, Maloney B, Holloway HW, Yu QS, Utsuki T, et al. The experimental Alzheimer\u2019s disease drug Posiphen lowers amyloid\u2013beta peptide levels in cell culture and mice. J Pharmacol Exp Ther. 2007;320:386\u201396.","journal-title":"J Pharmacol Exp Ther"},{"key":"377_CR81","doi-asserted-by":"crossref","unstructured":"Mikkilineni S, Cantuti-Castelvetri I, Cahill CM, Balliedier A, Greig NH, Rogers JT. The anticholinesterase phenserine and its enantiomer posiphen as 5'untranslated-region-directed translation blockers of the Parkinson's alpha synuclein expression. Parkinsons Dis. 2012;142372","DOI":"10.1155\/2012\/142372"},{"key":"377_CR82","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0169-328X(96)00297-5","volume":"46","author":"V Haroutunian","year":"1997","unstructured":"Haroutunian V, Greig N, Pei XF, Utsuki T, Gluck R, Acevedo LD, et al. Pharmacological modulation of Alzheimer's beta-amyloid precursor protein levels in the CSF of rats with forebrain cholinergic system lesions. Brain Res Mol Brain Res. 1997;46:161\u20138.","journal-title":"Brain Res Mol Brain Res"},{"key":"377_CR83","unstructured":"Sambamurti K, Prakasam A, Anitha S, Venugopa C, Cullen E, Zhou Y, et al. Oral phenserine tartrate treatment is associated with reduced plasma Ab 1-42 in a phase I clinical study. In, Alzheimer's disease new advances (Khalid Iqbal K, Winblad B, Avila J). Bologna: Medimond, via Maserati 5; 2007. p. 571\u20135."},{"key":"377_CR84","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/sj.mp.4001937","volume":"12","author":"AL Friedlich","year":"2007","unstructured":"Friedlich AL, Tanzi RE, Rogers JT. The 5\u2032-untranslated region of Parkinson's disease alpha-synuclein messenger RNA contains a predicted iron responsive element. Mol Psychiatry. 2007;12:222\u20133.","journal-title":"Mol Psychiatry"},{"key":"377_CR85","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.3390\/ijms10031226","volume":"10","author":"D Olivares","year":"2009","unstructured":"Olivares D, Huang X, Branden L, Greig NH, Rogers JT. Physiological and pathological role of alpha-synuclein in Parkinson's disease through iron mediated oxidative stress; the role of a putative iron-responsive element. Int J Mol Sci. 2009;10:1226\u201360.","journal-title":"Int J Mol Sci"},{"key":"377_CR86","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.bbagen.2008.12.001","volume":"1790","author":"CM Cahill","year":"2009","unstructured":"Cahill CM, Lahiri DK, Huang X, Rogers JT. Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases. Biochim Biophys Acta. 2009;1790:615\u201328.","journal-title":"Biochim Biophys Acta"},{"key":"377_CR87","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.3171\/jns.2003.98.5.1072","volume":"98","author":"DH Smith","year":"2003","unstructured":"Smith DH, Chen X, Iwata A, Graham DI. Amyloid beta accumulation in axons after traumatic brain injury in humans. J Neurosurg. 2003;98:1072\u20137.","journal-title":"J Neurosurg"},{"key":"377_CR88","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1089\/neu.2000.17.1041","volume":"17","author":"C Van Den Heuvel","year":"2000","unstructured":"Van Den Heuvel C, Finnie JW, Blumbergs PC, Manavis J, Jones NR, Reilly PL, et al. Upregulation of neuronal amyloid pre- cursor protein (APP) and APP mRNA following magnesium sulphate (MgSO4) therapy in trau- matic brain injury. Neurotrauma. 2000;17:1041\u201353.","journal-title":"Neurotrauma"},{"key":"377_CR89","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0006-8993(01)02758-5","volume":"913","author":"H Luth","year":"2001","unstructured":"Luth H, Holzer M, Gartner U, Staufenbiel M, Arendt T. Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer\u2019s disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology. Brain Res. 2001;913:57\u201367.","journal-title":"Brain Res"},{"key":"377_CR90","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1093\/jnen\/61.12.1056","volume":"61","author":"A Iwata","year":"2002","unstructured":"Iwata A, Chen X, McIntosh TK, Browne K, Smith D. Long-term accumulation of amyloid-beta in axons following brain trauma without persistent upregulation of amyloid pre- cursor protein genes. J Neuropathol Exp Neurol. 2002;61:1056\u201368.","journal-title":"J Neuropathol Exp Neurol"},{"key":"377_CR91","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1097\/00005072-199909000-00008","volume":"58","author":"DH Smith","year":"1999","unstructured":"Smith DH, Chen XH, Nonaka M, Trojanowski JQ, Lee VM, Saatman KE, Leoni MJ, Xu BN, Wolf JA, Meaney DF. Accumulation of amyloid and tau and the formation of neurofilament inclusions following diffuse brain injury in the pig. J Neuropathol Exp Neurol. 1999;58:982\u201392.","journal-title":"J Neuropathol Exp Neurol"},{"key":"377_CR92","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/mp.2009.82","volume":"14","author":"DK Lahiri","year":"2009","unstructured":"Lahiri DK, Maloney B, Zawia NH. The LEARn model: an epigenetic explanation for idiopathic neurobiological diseases. Mol Psychiatry. 2009;14:992\u20131003.","journal-title":"Mol Psychiatry"},{"issue":"7","key":"377_CR93","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S1474-4422(16)00065-X","volume":"15","author":"B Maloney","year":"2016","unstructured":"Maloney B, Lahiri DK. Epigenetics of dementia: understanding the disease as a transformation rather than a state. Lancet Neurol. 2016;15(7):760\u201374.","journal-title":"Lancet Neurol"},{"issue":"1-2","key":"377_CR94","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11010-008-0013-1","volume":"324","author":"T Itoh","year":"2009","unstructured":"Itoh T, Satou T, Nishida S, Tsubaki M, Hashimoto S, Ito H. Improvement of cerebral function by anti-amyloid precursor protein antibody infusion after traumatic brain injury in rats. Mol Cell Biochem. 2009;324(1-2):191\u20139.","journal-title":"Mol Cell Biochem"},{"key":"377_CR95","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/3305","volume":"4","author":"PS Eriksson","year":"1998","unstructured":"Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA, et al. Neurogenesis in the adult human hippocampus. Nat Med. 1998;4:1313\u20137.","journal-title":"Nat Med"},{"key":"377_CR96","doi-asserted-by":"publisher","first-page":"4710","DOI":"10.1073\/pnas.081011098","volume":"98","author":"K Jin","year":"2001","unstructured":"Jin K, Minami M, Lan JQ, Mao XO, Batteur S, Simon RP, et al. Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat. PNAS. 2001;98:4710\u20135.","journal-title":"PNAS"},{"key":"377_CR97","first-page":"332","volume":"10","author":"EH Chang","year":"2016","unstructured":"Chang EH, Adorjan I, Mundim MV, Sun B, Dizon ML, Szele FG. Traumatic brain injury activation of the adult subventricular zone Neurogenic niche. Front Neurosci. 2016;10:332.","journal-title":"Front Neurosci"},{"key":"377_CR98","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/ncomms2101","volume":"3","author":"C Vivar","year":"2012","unstructured":"Vivar C, Potter MC, Choi J, Lee JY, Stringer TP, Callaway EM, et al. Monosynaptic inputs to new neurons in the dentate gyrus. Nat Commun. 2012;3:1107.","journal-title":"Nat Commun"},{"key":"377_CR99","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fncir.2013.00015","volume":"7","author":"C Vivar","year":"2013","unstructured":"Vivar C, van Praag H. Functional circuits of new neurons in the dentate gyrus. Front Neural Circuits. 2013;7:15.","journal-title":"Front Neural Circuits"},{"key":"377_CR100","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/ana.21592","volume":"65","author":"Y Luo","year":"2009","unstructured":"Luo Y, Kuo CC, Shen H, Chou J, Greig NH, Hoffer BJ, et al. Delayed treatment with a p53 inhibitor enhances recovery in stroke brain. Ann Neurol. 2009;65:520\u201330.","journal-title":"Ann Neurol"},{"issue":"Pt 3","key":"377_CR101","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.expneurol.2015.04.017","volume":"275","author":"D Sun","year":"2016","unstructured":"Sun D. Endogenous neurogenic cell response in the mature mammalian brain following traumatic injury. Exp Neurol. 2016;275(Pt 3):405\u201310.","journal-title":"Exp Neurol"},{"issue":"Pt 3","key":"377_CR102","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.expneurol.2015.08.018","volume":"275","author":"DJ Loane","year":"2016","unstructured":"Loane DJ, Kumar A. Microglia in the TBI brain: the good, the bad, and the dysregulated. Exp Neurol. 2016;275(Pt 3):316\u201327.","journal-title":"Exp Neurol"},{"key":"377_CR103","doi-asserted-by":"publisher","first-page":"12506","DOI":"10.1073\/pnas.0705346104","volume":"104","author":"A Marutle","year":"2007","unstructured":"Marutle A, Ohmitsu M, Nilbratt M, Greig NH, Nordberg A, Sugaya K. Modulation of human neural stem cell differentiation in Alzheimer (APP23) transgenic mice by phenserine. PNAS. 2007;104:12506\u201311.","journal-title":"PNAS"},{"issue":"3","key":"377_CR104","doi-asserted-by":"publisher","first-page":"e58752","DOI":"10.1371\/journal.pone.0058752","volume":"8","author":"AM Lilja","year":"2013","unstructured":"Lilja AM, R\u00f6jdner J, Mustafiz T, Thom\u00e9 CM, Storelli E, Gonzalez D, et al. Modulation of amyloid-\u03b2 enhances hippocampal neurogenesis in adult Tg2576 mice. PLoS One. 2013;8(3):e58752.","journal-title":"PLoS One"},{"key":"377_CR105","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1136\/jnnp.52.3.346","volume":"52","author":"DI Graham","year":"1989","unstructured":"Graham DI, Ford I, Adams JH, et al. Ischaemic brain damage is still common in fatal non-missile head injury. J Neurol Neurosurg Psychiatry. 1989;52:346\u201350.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"377_CR106","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/bja\/57.1.120","volume":"57","author":"JD Miller","year":"1985","unstructured":"Miller JD. Head injury and brain ischaemia-implications for therapy. Br J Anaesth. 1985;57:120\u201330.","journal-title":"Br J Anaesth"},{"key":"377_CR107","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1001\/jamaneurol.2016.0091","volume":"73","author":"TV Veenith","year":"2016","unstructured":"Veenith TV, Carter EL, Geeraerts T, Grossac J, Newcombe VF, Outtrim J, et al. Pathophysiologic mechanisms of cerebral ischemia and diffusion hypoxia in traumatic brain injury. JAMA Neurol. 2016;73:542\u201350.","journal-title":"JAMA Neurol"},{"key":"377_CR108","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.neurobiolaging.2007.10.009","volume":"30","author":"Y Wang","year":"2009","unstructured":"Wang Y, Greig NH, Yu QS, Mattson MP. Presenilin-1 mutation impairs cholinergic modulation of synaptic plasticity and suppresses NMDA currents in hippocampus slices. Neurobiol Aging. 2009;30:1061\u20138.","journal-title":"Neurobiol Aging"},{"key":"377_CR109","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2174\/1567205054367829","volume":"2","author":"NH Greig","year":"2005","unstructured":"Greig NH, Sambamurti K, Yu QS, Brossi A, Bruinsma GB, Lahiri DK. An overview of phenserine tartrate, a novel acetylcholinesterase inhibitor for the treatment of Alzheimer's disease. Curr Alzheimer Res. 2005;2:281\u201390.","journal-title":"Curr Alzheimer Res"},{"key":"377_CR110","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1034\/j.1600-0404.2000.00311.x","volume":"176","author":"NH Greig","year":"2000","unstructured":"Greig NH, De Micheli E, Holloway HW, Yu QS, Utsuki T, Perry TA, et al. The experimental Alzheimer drug phenserine: preclinical pharmacokinetics and pharmacodynamics. Acta Neurol Scand Suppl. 2000;176:74\u201384.","journal-title":"Acta Neurol Scand Suppl"},{"key":"377_CR111","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jneumeth.2016.02.002","volume":"272","author":"H Deselms","year":"2016","unstructured":"Deselms H, Maggio N, Rubovitch V, Chapman J, Schreiber S, Tweedie D, et al. Novel pharmaceutical treatments for minimal traumatic brain injury and evaluation of animal models and methodologies supporting their development. J Neurosci Methods. 2016;272:69\u201376.","journal-title":"J Neurosci Methods"},{"key":"377_CR112","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12974-015-0237-4","volume":"12","author":"R Baratz","year":"2015","unstructured":"Baratz R, Tweedie D, Wang JY, Rubovitch V, Luo W, Hoffer BJ, et al. Transiently lowering tumor necrosis factor-\u03b1 synthesis ameliorates neuronal cell loss and cognitive impairments induced by minimal traumatic brain injury in mice. J Neuroinflammation. 2015;12:45.","journal-title":"J Neuroinflammation"},{"key":"377_CR113","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/ana.21345","volume":"63","author":"A Kadir","year":"2008","unstructured":"Kadir A, Andreasen N, Almkvist O, Wall A, Forsberg A, Engler H, et al. Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease. Ann Neurol. 2008;63:621\u201331.","journal-title":"Ann Neurol"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-017-0377-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12929-017-0377-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-017-0377-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T20:51:05Z","timestamp":1719435065000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/s12929-017-0377-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,9]]},"references-count":113,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["377"],"URL":"https:\/\/doi.org\/10.1186\/s12929-017-0377-1","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,9]]},"assertion":[{"value":"20 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Robert E. Becker does not have a competing interest but a conflict of interest. For disclosure, Robert E. Becker holds a patent on the use of phenserine in concussion\/TBI and Alzheimer\u2019s disease assigned to Aristea Translational Medicine Corporation of Utah. None of the other authors have any competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"71"}}